Back to Search
Start Over
Exclusive-China In Talks With Pfizer For Generic COVID Drug - Sources
- Source :
- International Business Times - US ed. January 8, 2023
- Publication Year :
- 2023
-
Abstract
- China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug [...]
- Subjects :
- Pfizer Inc. -- Licensing agreements -- International economic relations
Generic drugs -- Licensing agreements
Antiviral agents -- Licensing agreements
Pharmaceutical industry -- International economic relations -- Licensing agreements
Company licensing agreement
Business, international
News, opinion and commentary
Paxlovid (Medication) -- Licensing agreements
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- International Business Times - US ed.
- Publication Type :
- News
- Accession number :
- edsgcl.732505564